Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 80Thoracic 26Gynecologic 21Genitourinary 18Head & Neck 16Breast 16Dermatologic 10Sarcoma 5CNS 4Other hematologic neoplasm 3Plasma cell 2Lymphoid 2Other solid neoplasm 1Other 1NET 1Myeloid 1Endocrine 1

Conditions

Neuroendocrine Tumors 34Pheochromocytoma 4Paraganglioma 4Carcinoma, Neuroendocrine 4Sarcoma 3Pancreatic Neoplasms 3Neoplasms 3Meningioma 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Carcinoid Tumor 3Adenoma, Islet Cell 3Thyroid Neoplasms 2Stomach Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Melanoma 2Medulloblastoma 2Liver Neoplasms 2Insulinoma 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Gastro-enteropancreatic neuroendocrine tumor 2Digestive System Neoplasms 2Colonic Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × NET × 30 days × Clear all
NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Case Comprehensive Cancer Center

Phase NA Recruiting
200 enrolled
EndocrineGastrointestinalNET

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡